Record IPO Supply Meets a Liquidity Squeeze

The IPO market is having its biggest year in a generation, and the supply is only getting started. U.S. equity issuance hit a record $251 billion in the first half of 2026^[1], with operating companies raising $140 billion through July 10 — already within striking distance of 2021’s full-year record of $141 billion^[2]. SpaceX alone raised $75 billion in its June debut ($86 billion including the greenshoe), and SK Hynix added $26.5 billion as the largest U.S. IPO by a foreign company^[2]. The Nasdaq IPO Pulse, a cyclical indicator of listing activity, remains near its 1.5-year high, suggesting the upswing continues into late 2026^[2].

But the issuance calendar is colliding with a liquidity backdrop that is deteriorating at precisely the wrong moment. Treasury bill settlements are draining cash from the financial system at their heaviest pace of the year, dealer gamma positioning has flipped negative after the July options expiration, and the biggest lockup unlock in IPO history is arriving in less than two weeks. Whether the market can absorb this wall of supply — or whether supply meets thinning demand — is the structural question of the summer.

The SpaceX Lockup Overhang

SpaceX (NASDAQ: SPCX) priced its IPO at $135 on June 11 and began trading the next day^[3]. Shares rocketed to $225.64 in mid-June before collapsing to $115.07 on July 24 — a 49% decline from the peak^[4]. The stock has now spent more than a week trading below its IPO price.

The proximate catalyst for the next leg is August 6, two business days after SpaceX reports its first earnings as a public company on August 4^[5]. On that date, roughly 911.5 million shares — 20% of the locked-up stock — will enter the tradable float^[5]. An additional 455.8 million shares (10%) may unlock the same day if the stock traded at least 30% above the $135 IPO price for 5 of the 10 consecutive trading days ending on the earnings release date^[5]. Given that SPCX is trading near $115, that conditional tranche will almost certainly remain locked — but the 20% tranche alone is enough to matter.

More tranches follow: approximately 319 million shares unlock around August 21, and another 319 million around September 10^[5]. Ultimately, more than 6.4 billion shares could enter the market over the next year, against an IPO float of just 629 million shares^[6]. Elon Musk’s personal stake of 6.4 billion shares remains locked until June 2027 with no early-release provisions^[5].

The scale is unprecedented. Matthew Kennedy of Renaissance Capital notes that the average IPO floats about 20% of its shares, while SpaceX floated only about 5%. “SpaceX has the longest series of lock-up releases we’ve ever seen,” he said^[6]. Morningstar analyst Nicolas Owens is more direct: “We believe that most of the available shares will come to market, because the existing sellers have low cost basis and long holding periods”^[6]. He adds that “it’s conceivable that a good deal of the recent slump in SpaceX stock is precisely in anticipation of the dilution from the lockup”^[6].

The Index Fund Feedback Loop

The unlock creates a secondary, less obvious effect. As the float rises, SpaceX’s weight in cap-weighted index funds increases — even if the price stays flat. Morningstar’s Zachary Evens points out that the Invesco QQQ Trust already held roughly 39.7 million shares of SpaceX as of July 22, worth $4.57 billion at a 0.98% weight^[6]. A tripling of the float-adjusted market cap would place SpaceX between Walmart and Intel in the Nasdaq-100^[6].

“Every lockup expiration is an opportunity for SpaceX to claim a greater share of cap-weighted index funds,” Evens says^[6]. That means passive strategies will be forced buyers — but Owens doubts they will be enough: “Unless something changes the fundamental story or sentiment — like for the better — the supply from these lockups will outweigh demand even from index funds”^[6].

The IPO Pipeline Behind SpaceX

The SpaceX overhang is not arriving in isolation. The broader pipeline is stacked with names that could dwarf anything outside the SpaceX deal itself.

Anthropic confidentially filed its S-1 on June 1, 2026, at a $965 billion valuation, followed exactly one week later by OpenAI’s confidential filing at an $852 billion mark^[7]. Goldman Sachs and Morgan Stanley are bookrunning both deals, each expected to raise at least $60 billion^[7]. Anthropic has already begun scheduling investor meetings, with CNBC reporting that Goldman, Morgan Stanley, and JPMorgan are gauging investor appetite^[7]. The combined AI listing pipeline behind SpaceX approaches $3.6 trillion in target market capitalization^[7].

Smaller deals are already testing the water. Scribe Therapeutics (Nasdaq: SCTX), a CRISPR gene-editing company co-founded by Jennifer Doudna, priced an upsized IPO at $15 per share on July 23 — the high end of its $13–$15 range — raising $128.7 million^[8]. The deal is being read as a temperature check on biotech appetite in the second half^[8]. The broader 2026 IPO pipeline includes names like Shield AI, Perplexity, Cohere, Revolut, Quantinuum, and Saronic^[9].

Meanwhile, corporate buyback activity remains active but is dominated by European names — Equinor commenced a third tranche of up to $1.125 billion^[10], A.P. Møller-Mærsk is executing a $1 billion program^[10], and Flagstar Bank announced a $250 million authorization on July 24^[10]. The buyback bid, in other words, is steady but not accelerating — it will not meaningfully offset the incoming supply wall.

The Liquidity Drain

The supply story is only half the equation. The other half is what is happening to the cash that would absorb it.

Treasury bill settlements are pulling liquidity out of the financial system at an accelerating clip. The week of July 14 alone saw about $65 billion in net new settlements^[11]. The following week brought $56 billion on July 21 and $37 billion on July 23^[11]. This pattern is expected to continue through the last week of July before beginning to diminish in August, with a potential flip to paydowns — which would add liquidity back — around early to mid-September^[11].

The statistical footprint is clear. Since November, on T-bill settlement dates, the Technology Select Sector SPDR (XLK) has risen only 45% of the time with an average decline of 41 basis points, compared to a 66% win rate and average gain of 26 basis points on non-settlement dates^[11]. The S&P 500 shows the same pattern: 45% win rate on settlement dates versus 60% on non-settlement dates, with larger average declines when the market does fall^[11].

The implication is straightforward. The period between now and early September — exactly when the SpaceX unlock tranches hit — is statistically the most difficult stretch for equities in the T-bill settlement cycle. Liquidity is being drained at the same time new share supply is arriving.

Negative Gamma: The Dealer Amplifier

Layered on top of the supply-and-liquidity dynamic is a shift in options dealer positioning that has changed the character of the tape.

After the July monthly options expiration, the dealer gamma book flipped negative^[12]. Gamma exposure, a measure of how much dealers must buy or sell to stay hedged as the market moves, turned to approximately -79,314^[12]. The “flip” level — the point at which positive gamma becomes negative — sits around 7,500 on the S&P 500^[13]. With the index closing at 7,457.69 after the expiration^[12], the market is trading below that threshold.

In a positive-gamma regime, dealers buy when the market dips and sell when it rises, dampening volatility. In a negative-gamma regime, the dynamic reverses: dealers must sell into declines to cover their delta exposure, amplifying moves in both directions. “We are in a negative gamma regime,” said Brendan Herbert, options product manager at Barchart. “If we drop, market makers are going to have to sell to cover deltas, so they could in theory make a downward move more intense”^[13].

SpotGamma founder Brent Kochuba wrote that while the degree of positive gamma has lessened, there is still a “fairly light amount of positive gamma” through to the 7,300 level, and that the S&P 500 has fallen below a “risk pivot”^[13]. The 10-year Treasury yield touching 4.7% — its highest since January 2025 — adds a rates-driven headwind to an already fragile positioning setup^[13].

Structure Is the Story

Citadel Securities’ Scott Rubner captured the broader backdrop in his 1H 2026 Market Structure & Flows review, published June 30. “Markets entering the second half of 2026 bear little resemblance to the markets investors navigated for most of the past two decades,” Rubner wrote. “The defining story of 2026 has not been a single macro event, it has been the structural transformation of equity markets”^[14].

Rubner’s earlier May note, titled “Flow Fragility,” warned that the market was “vulnerable to a potential flow-of-funds unwind” after the S&P 500 added roughly $10 trillion in market cap from its March 30 low^[14]. By mid-July, he was noting that equal-weight benchmarks were outperforming — a sign that the concentration that drove the rally was cracking, and that market leadership was broadening even as the index itself struggled^[14].

The structural point matters here. A market where leadership is rotating, where flows are fragile, and where the dealers’ gamma buffer has expired is not the same market that absorbed the SpaceX IPO in June. The plumbing has changed between when the shares were issued and when the lockups will release.

The Convergence in One Table

What to Watch Next

• SpaceX earnings on August 4. The report itself will matter, but the more important date is August 6 — the lockup expiration. Watch for volume spikes and whether the stock can hold above $111, its recent intraday low^[4].
• The 7,500 gamma flip level on the S&P 500. If the index reclaims it, dealers shift back to dampening volatility. If it stays below, every dip risks dealer selling that makes the dip deeper^[13].
• T-bill settlement calendar. The heaviest drain runs through the last week of July. If settlements begin diminishing on schedule in August, the liquidity headwind eases. A paydown flip in September would add cash back to the system^[11].
• Anthropic and OpenAI timing. Anthropic is already holding investor meetings^[7]. If either company prices before the SpaceX lockup overhang clears, the market will face a second supply event layered on top of the first.
• Index rebalancing dates. As SpaceX’s float increases, index providers will adjust weightings. The timing of those reviews — typically quarterly — will determine how quickly passive funds become forced buyers^[6].

The base case is not a crash. It is a market where the supply of shares is rising faster than the liquidity available to absorb them, where the dealer buffer that smoothed the June rally has expired, and where the Treasury is actively draining cash from the system through Labor Day. Each of these factors is manageable in isolation. The question is whether they compound — and the answer arrives in the second week of August.